Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
4/23/24 Neurocrine Biosciences (NBIX) NBI-1065845 for Major Depressive Disorder (MDD) Subscribers Only Subscribers Only Subscribers Only
4/18/24 AbbVie (ABBV) Rinvoq for Giant Cell Arteritis Subscribers Only Subscribers Only Subscribers Only
4/17/24 Eli Lilly (LLY) Mounjaro for Sleep Apnea Subscribers Only Subscribers Only Subscribers Only
4/16/24 Amgen (AMGN) Tezspire for Chronic Obstructive Pulmonary Disease (COPD) Subscribers Only Subscribers Only Subscribers Only
4/16/24 Intra-Cellular Therapies (ITCI) Caplyta for Major Depressive Disorder (MDD) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
03/01/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
03/19/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
04/09/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
04/15/24 Subscribers Only Subscribers Only Partnership - Acquisition Completion
04/15/24 Subscribers Only Subscribers Only Partnership - Acquisition Completion